Laboratory confirmation of Buruli ulcer disease in Togo, 2007-2010

• Published in: PLoS neglected tropical diseases 2011-07, Vol.5 (7), p.e1228-e1228
• Main Authors: Bretzel, Gisela, Huber, Kristina Lydia, Kobara, Basil, Beissner, Marcus, Piten, Ebekalisai, Herbinger, Karl-Heinz, Wiedemann, Franz Xaver, Amekuse, Komi, Banla Kere, Abiba, Helfrich, Kerstin, Fleischmann, Erna, Löscher, Thomas, Diefenhardt, Adolf, Nitschke, Jörg
• Format: Article
• Language: English
• Subjects: Adolescent; Aged; Antiulcer drugs; Buruli ulcer; Buruli Ulcer - diagnosis; Buruli Ulcer - epidemiology; Buruli Ulcer - microbiology; Chi-Square Distribution; Child; Child, Preschool; Diagnosis; Drug therapy; Female; Health aspects; Humans; Infant; Medicine; Middle Aged; Mycobacterium ulcerans - isolation & purification; Polymerase Chain Reaction; Prevalence; Retrospective Studies; Togo - epidemiology; Tropical Medicine
• ISSN: 1935-2735; 1935-2727; 1935-2735
• DOI: 10.1371/journal.pntd.0001228

Since the early 1990s more than 1,800 patients with lesions suspicious for Buruli ulcer disease (BUD) have been reported from Togo. However, less than five percent of these were laboratory confirmed. Since 2007, the Togolese National Buruli Ulcer Control Program has been supported by the German Leprosy and Tuberculosis Relief Association (DAHW). Collaboration with the Department for Infectious Diseases and Tropical Medicine (DITM), University Hospital, Munich, Germany, allowed IS2404 PCR analysis of diagnostic samples from patients with suspected BUD during a study period of three years. The DAHW integrated active BUD case finding in the existing network of TB/Leprosy Controllers and organized regular training and outreach activities to identify BUD cases at community level. Clinically suspected cases were referred to health facilities for diagnosis and treatment. Microscopy was carried out locally, external quality assurance (EQA) at DITM. Diagnostic samples from 202 patients with suspected BUD were shipped to DITM, 109 BUD patients (54%) were confirmed by PCR, 43 (29.9%) by microscopy. All patients originated from Maritime Region. EQA for microscopy resulted in 62% concordant results. This study presents a retrospective analysis of the first cohort of clinically suspected BUD cases from Togo subjected to systematic laboratory analysis over a period of three years and confirms the prevalence of BUD in Maritime Region. Intensified training in the field of case finding and sample collection increased the PCR case confirmation rate from initially less than 50% to 70%. With a PCR case confirmation rate of 54% for the entire study period the WHO standards (case confirmation rate ≥50%) have been met. EQA for microscopy suggests the need for intensified supervision and training. In January 2011 the National Hygiene Institute, Lomé, has assumed the role of a National Reference Laboratory for PCR confirmation and microscopy.